Resonant Medical
3D ultrasound image-guided adaptive radiotherapy products manufacturer
About Resonant Medical
Resonant Medical Inc., founded in 2000 and based in Montreal, Canada, developed and commercialized 3D ultrasound image-guided adaptive radiotherapy products. The company was established based on research from McGill University. One of the founders was Tony Falco, Ph.D., who served as the company's CEO and had over 15 years of experience in advanced imaging technology. He created a 3D and 4D imaging technology to better target tumors while sparing healthy tissue, an improvement over the imprecise X-ray imaging of the late 1990s.
The company's main product was the Clarity system, a non-invasive, radiation-free image guidance solution for conformal cancer treatments. This system was developed to provide superior visualization of soft tissue anatomy during the radiotherapy process, improving treatment accuracy for cancers such as prostate, breast, liver, and cervix. The technology was compatible with linear accelerators and CT scanners from all manufacturers. Resonant Medical's products, including the FDA-cleared Restitu Platform, were used in cancer centers and academic institutions across North America and Europe.
In December 2005, Resonant Medical secured a significant Series B funding round of $24 million from investors including Ventures West, MDS Capital, Lumira Ventures, and Rosetta Capital. This investment was aimed at expanding its product applications for head & neck, breast, and gynecological cancers. On March 31, 2010, the company was acquired by Elekta AB, a Swedish human-care company, for CAD 30 million (approximately $29.4M USD). The acquisition integrated Resonant's soft tissue visualization technology into Elekta's portfolio of cancer treatment solutions.
Source: Dealroom company dataNews
Open roles
Resonant Medical in the Montreal ecosystem
The Resonant Medical office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A5 investors entered at this stage
Bank Of Canada
MMV Financial
Desjardins Capital- MCMDS Capital
Ventures West
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Resonant Medical on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Resonant Medical on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.